Delivery Order SPE2DB22D3301-SPE2DB24FZ0XM
Award Date
7/18/24
Potential Completion Date
7/19/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Gadavist, a 1 mmol/ml bulk medication vial. The delivery order has a ceiling value of $1,711.35 and a period of performance through October 17, 2024. This award is not designated as a set-aside contract.
The contract is a Firm Fixed Price delivery order under a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $1,573.54, is for the supply of Gadavist 10 mmol/10 ml vial, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.51 firm fixed-price delivery order is for the supply of Gadavist, a 1 mmol/ml bulk vial medication, with a performance period ending on December 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GADAVIST 10 MMOL/10 ML SYRINGE 10ML. The contract has a ceiling value of $1,246.14 and a period of performance through October 17, 2024. It is a Firm Fixed Price contract, indicating a predetermined unit cost for the products.
The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $3,884.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Gadavist 10 mmol/10 ml vial (10 ml). This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Gadavist, a pharmaceutical product. The contract has a ceiling value of $22,522.21 and an ultimate completion date of September 4, 2024. It is a firm fixed price contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the Gadavist product to support the medical needs of military treatment facilities and...
The U.S. Defense Logistics Agency (DLA) awarded a $1,180.34 firm fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Gadavist 1 mmol/ml bulk vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is for the delivery of Gadavist 10 mmol/10 ml vial (10 ml) to the Defense Logistics Agency (DLA). The $1,165.20 firm fixed price delivery order contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceuticals and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the supply of the pharmaceutical product Gadavist (7.5 mmol/7.5 ml vial, 7.5 ml) to the Defense Logistics Agency (DLA). The $1,071.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Gadavist 10 mmol/10 ml vials. The $4,729.46 order has a completion date of January 30, 2024 and does not fall under any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...